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SHORT COMMUNICATION
Ligneous membranitis in Scottish Terriers is associated with a single
nucleotide polymorphism in the plasminogen (PLG) gene
Stuart Ainsworth*, Stuart Carter*, Claire Fisher†, Jenna Dawson*, Loria Makrides*, Tim Nuttall†
and Sarah L. Mason‡
*Department of Infection Biology, Institute of Infection and Global Health, University of Liverpool, ic2 Building, Liverpool L3 5RF, UK.
†Royal (Dick) School of Veterinary Studies, University of Edinburgh, Easter Bush Campus, Roslin EH25 9RG, UK. ‡School of Veterinary
Science, Small Animal Teaching Hospital, University of Liverpool, Leahurst Campus, Chester High Road, Neston CH64 3TF, UK.
Summary Ligneous membranitis (LM) is a rare chronic inflammatory condition of the mucous
membranes associated with plasminogen (encoded by PLG) deficiency in affected humans
and dogs. In human, the condition is genetic in nature with numerous mutations and
polymorphisms in PLG identified in affected individuals and related family members. The
condition is uncommonly reported in dogs and, to date, no genetic studies have been
performed. We identified related Scottish Terriers (littermates) with severe LM and
unaffected relatives (sire, dam and a sibling from a previous litter). Plasma plasminogen
activity was below normal in one affected dog but within normal reference intervals for the
other. Sequencing of PLG from the affected dogs revealed a homozygous A>T single
nucleotide polymorphism in an intron donor site (c.1256+2T>A). The related, unaffected
dogs displayed heterozygous alleles at this position (c.1256+2T/A), whereas no mutation
was detected in unaffected, non-related control dogs. This is the first report to identify gene
polymorphisms associated with LM in dogs.
Keywords chronic inflammation, fibrinous lesions, hypoplasminogenemia, intron donor
site, mucous membranes
Plasminogen has an important role in many physiological
processes including embryogenesis, wound healing, fibri-
nolysis, cell migration and angiogenesis (Drew et al. 1998;
Cesarman-Maus & Hajjar 2005; Miles et al. 2014). Ligneous
membranitis (LM) is a rare chronic inflammatory disease
associated with congenital plasminogen deficiency. The
inherited condition is well described in humans (Mingers
et al. 1999; Schuster et al. 2001, 2007; Tefs et al. 2006;
Rodrıguez-Ares et al. 2007); patients commonly present as
infants, with ocular, oral and genital lesions (Schott et al.
1998; Tefs et al. 2006; Zare et al. 2010). Patients with LM
are frequently found to harbour homozygous or compound
heterozygous mutations within the plasminogen gene, PLG,
including nonsense, splice-site and frame-shift mutations
(Tefs et al. 2003, 2004, 2006; Rodrıguez-Ares et al. 2007;
Schuster et al. 2007).
Ligneous membranitis has been reported in only six
unrelated dogs to date (Ramsey et al. 1995; McLean et al.
2008; Torres et al. 2009). The clinical presentation is
similar to that in humans, and low plasma plasminogen
activity has been documented in two affected dogs (McLean
et al. 2008; Torres et al. 2009).
In this study, two related Scottish Terriers (littermates,
one male and one female) presented with biopsy-confirmed
LM. Both developed severe proliferative and ulcerative
conjunctivitis and gingivitis/stomatitis by 2 months of
age. Other clinical signs included increased upper respira-
tory tract noise, nasal discharge and lymphadenopathy.
Clinical pathological findings included neutrophilia, pro-
teinuria and hypoalbuminaemia. No significant clinical
improvement was seen despite supportive treatment, and
the affected dogs were euthanised due to progressive clinical
signs. Post-mortem evaluation of the euthanised dogs
revealed multiple abnormalities including severe prolifera-
tive fibrinous lesions affecting the trachea, larynx and
epicardium and multiple fibrous adhesions throughout the
thoracic and abdominal cavities. Clinical signs in the
affected Scottish Terriers were similar to those reported
previously in a Golden Retriever with LM (McLean et al.
2008) but more severe than those reported in affected
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Dobermanns (Ramsey et al. 1995) and a Yorkshire Terrier
(Torres et al. 2009). Hence, this condition may display
clinical heterogeneity, which may be breed or family
related. A juvenile dog from an earlier litter to the same
parents also had been diagnosed with LM and also was
euthanised (samples not available for this study).
To further investigate the nature of LM in Scottish
Terriers, blood samples were obtained for sequencing of PLG
and to determine plasminogen activity. Samples were
available for two of three affected dogs reported in this
study; three related, unaffected dogs (which consisted of the
sire, dam and an adult dog which was the offspring of the
same parents from an earlier litter) and four healthy control
Scottish Terriers, unrelated to the affected, which were
presenting for signs unrelated to LM. Ethical approval was
granted by the institute’s ethics committee, and informed
consent was obtained from the owners of all dogs included
in the study.
Blood was collected via standard venepuncture tech-
niques. Whole blood in EDTA for DNA extraction was stored
at 20 °C, and citrated plasma for plasminogen assay was
immediately separated and frozen at 20 °C. Plasminogen
assays were performed at the Animal Health Diagnostic
Centre, Cornell University, USA. Plasminogen activity was
measured by a standard chromatogenic assay validated for
dogs (Welles et al. 1990; Lanevschi et al. 1996). Total
genomic DNA was isolated from blood samples using a
DNeasy Blood & Tissue Kit (Qiagen) as per the manufac-
turer’s instructions.
Thirteen sets of primers (Table S1) to amplify the 19
identified PLG exons (Petersen et al. 1990) were designed
using the PLG nucleotide sequence (GenBank accession no.
NC_006583.3) from Canis lupus familiaris (Lindblad-Toh
et al. 2005) as a template. The majority of PCR products
were generated using high-fidelity KOD DNA polymerase
(Invitrogen) with added 1 M betaine as required. Where
indicated, persistently difficult PCRs were performed with
Phusion High Fidelity DNA polymerase (Thermo Scientific).
All amplicons were sequenced at least twice from two
independent PCRs (performed by Beckman Coulter Geno-
mics). Reads were assembled and mutations identified using
DNA BASER SEQUENCE ASSEMBLER v4.13.0 (Heracle BioSoft SRL;
www.DnaBaser.com). Mutations were confirmed by further
two sequencing reactions from independent PCRs.
Sequences encompassing the identified mutation were
submitted to GenBank under the following accession
numbers: Affected 1 (KP853099), Affected 2 (KP853100),
Sire (KP853101), Dam (KP853102), R-control (KP853
103), NR-Control 1 (KP853104), NR-Control 2 (KP853
105), NR-Control 3 (KP853106), NR-Control 4 (KP85
3107).
Sequencing of all 19 PLG exons and flanking sequences
from nine Scottish Terriers (two affected dogs, sire, dam, a
related non-affected control and four unrelated, non-
affected controls) found no mutations within any coding
regions of PLG. However, the affected dogs demonstrated a
single nucleotide change within an intron donor site
downstream of exon 10 (c.1256+2T>A) compared to the
reference sequence (GenBank accession no.: NC_0065
83.3). The sire, dam and related control displayed heterozy-
gous alleles (c.1256+2T/A) at this position. All unrelated,
non-affected controls displayed wild-type (wt) PLG
sequences. A further 23 healthy Scottish Terriers were
investigated, and all had a wt genotype at this position (data
not shown). Similar splice-site mutations have previously
been noted in affected humans with LM (Schuster et al.
2007). The non-carriage of c.1256+2T/A in 24 normal
Scottish Terriers indicates that carriers of the mutation are
generally not common in this breed.
The identified c.1256+2T>A genotype in affected Scottish
Terriers is predicted to adversely affect translation of PLG
mRNA downstream of exon 10 and may result in a
potential truncation of PLG from amino acid position 419.
This would presumably lead to the loss of two kringle
domains and the proteolytic trypsin domain, thereby
severely affecting PLG functionality (Novokhatny et al.
1984; Law et al. 2012, 2013).
Serum plasminogen activity was determined for the
affected dogs, their relatives and healthy controls. Plas-
minogen activity (reference interval 70–140%) was low
(45%) in one affected dog and within reference intervals
(95%) in the other (Table 1). Although normal serum
plasminogen activity in people with LM has been reported
(Naudi et al. 2006; Fuentes-Paez et al. 2008), the literature
for humans supports hypoplasminogenemia as the most
likely cause of LM (Schuster et al. 2007). Therefore, it is
difficult to explain the apparently normal plasminogen
activity in the affected male. This result may reflect
inaccuracies in the assay or the canine reference interval;
Table 1 Patient details, plasma plasminogen activity and detected PLG
mutations in Scottish Terriers.




Affected 1 M Puppy Affected 95 c.1256+2T>A
Affected 2 F Puppy Affected 49 c.1256+2T>A
Sire M Adult Healthy 124 c.1256+2T/A
Dam F Adult Healthy 111 c.1256+2T/A





F Adult Healthy 76 WT
NR-
Control 2
F Adult Healthy 101 WT
NR-
Control 3
F Adult Healthy 108 WT
NR-
Control 4
M Adult Healthy 100 WT
M, male; F, female; R, related; NR, non-related; RI, reference interval.
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however, we were unable to re-assess this as the patient
died. Surprisingly, the non-affected adult relative with a
c.1256+2T/A genotype displayed low plasminogen activity.
A repeat assay, to ascertain whether this result was
reproducible, was performed and provided a similar low
activity result (Table 1). This dog has no history or clinical
signs of LM. Hypoplasminogenemia without the presence of
clinical signs has previously been reported in healthy
relatives of humans with LM (Tefs et al. 2006). The dam
and sire of the affected dogs and all control dogs all had
plasminogen activity within reference intervals.
As in some cases of LM in humans, the link between
clinical LM and PLG genotype may not be consistently
clear in canines. It is possible that plasminogen may be
only one factor involved in the clinical syndrome and that
the identified PLG mutation is not enough alone to cause
clinical signs of LM. This also suggests the potential for
other abnormalities in proteins in the fibrinolytic pathway
and/or that an environmental factor is involved in
development of the condition (Fuentes-Paez et al. 2008).
Given the possibility of a truncated plasminogen protein
that lacks proteolytic activity in affected individuals, it is
possible that other proteins are able to provide compen-
sating functions which may also be abnormal in affected
patients.
In conclusion, this is the first report of a genetic alteration
in a family of dogs with LM, and our findings of a mutation
in PLG are similar to data from families of affected humans.
A screening programme via PCR and sequencing of the
region harbouring the identified SNP in Scottish Terriers
could be used for definitive diagnosis of the condition in
affected animals and determination of carriage rates in
other dog breeds.
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